Trial Profile
A Multicentre, Double-Blind, Placebo-Controlled Study of the Recovery Benefits Following Treatment With a Cox-2 Regimen in Patients Undergoing Elective Laparoscopic Intra-Peritoneal Abdominal Surgery.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Parecoxib (Primary) ; Valdecoxib (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Pfizer
- 23 Apr 2008 New trial record.